Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube
The Official News & Technical Journal Of The International Society For Pharmacoeconomics And Outcomes Research
ISPOR CORNER

ISPOR 3rd Asia Pacific Conference Scientific Awards Recipients

Stephen Priori, Director, ISPOR Publications


The ISPOR Best Contributed Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences. At the ISPOR 3rd Asia Pacific Conference, the ISPOR Research Award judges evaluated 60 podium presentations and nominated posters from 200 poster presentations. All podium presentations are considered for an award. Poster presentations in the top 30%, based on abstract review score, are considered and eligible for a poster presentation award.

Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

AND THE RECIPIENTS ARE . . .

ISPOR Best Contributed Podium Presentation Awards

CE3: COST-EFFECTIVENESS OF SMOKING CESSATION IN AUSTRALIA WITH VARENICLINE, A NOVEL PHARMACOTHERAPY
Brown A1, Webb K2, Kim H3, Liew D4, 1Pfizer Australia Pty Limited, West Ryde, NSW, Australia, 2Pfizer Inc, Tadworth, Surrey, United Kingdom, 3Pfizer Inc, Sydney, NSW, Australia, 4University of Melbourne, Melbourne, Victoria, Australia

CH3: ECONOMIC BURDEN OF SMOKING IN CHINA
Li L1, Chen Q1, Cui X1, Yu J1, Jia R2, 1Peking University, Beijing, China, 2Stockholm University, Stockholm, Sweden

JA3: COST-EFFECTIVENESS ANALYSIS OF SCREENING FOR IRON-DEFICIENCY ANEMIA IN MIDDLE-AGED WOMEN IN JAPAN
Sakai M, Shimbo T, Takahashi Y, Research Institute, International Medical Center of Japan, Shinjyuku-ku, Tokyo, Japan

KO3: HEALTH STATE UTILITY ASSESSMENT BY EQ5D IN CHRONIC HEPATITIS B PATIENTS IN KOREA
Lee YR1, Kwon SY2, Lee YS3, Lee JH4, Choi HM1, Lee CH2, 1GlaxoSmithKline, Seoul, South Korea, 2Konkuk University, Seoul, South Korea, 3Catholic University of Korea, Bucheon, South Korea, 4Sungkyunkwan University, Seoul, South Korea

PR2: HEALTH RELATED QUALITY OF LIFE AND ITS ASSOCIATED FACTORS IN PATIENTS WITH TYPE 2 DIABETES IN SOUTH KOREA
Jo MW1, Lee WJ2, Noh JH3, Song KH4, Choi YJ5, 1Dongguk University, Gyeongju, Gyeongbuk, South Korea, 2Inje University Sanggye Paik Hospital, Seoul, South Korea, 3Inje University Ilsan Paik Hospital, Ilsan, Gyeonggi-Do, South Korea, 4Kunkuk University Hospital, Seoul, South Korea, 5Sanofi-Aventis Korea, Seoul, South Korea

TH3: COST-UTILITY ANALYSIS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN CANCER PATIENTS WITH ANEMIA INDUCED BY CHEMOTHERAPY IN THAILAND
Roungrong J1, Teerawattananon Y1, Chaikledkaew U2, 1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand

ISPOR Best Contributed Poster Presentation Awards

PDB9: INCREMENTAL TREATMENT COSTS ATTRIBUTABLE TO OBESITY IN PATIENTS WITH DIABETES MELLITUS IN THE U.S.
Suh DC1, Jang EJ1, Kim CM2, Jung JC3, Jang SM4, 1Rutgers University, Piscataway, NJ, USA, 2Catholic University, Seoul, Suhcho-gu, South Korea, 3Korea National Health Insurance Corporation, Mapo-gu, Seoul, South Korea, 4Health Insurance Review & Assessment Service, Seoul, South Korea

PDB10: EFFECT OF ANTIHYPERGLYCEMIC MEDICATION ADHERENCE ON HOSPITALIZATION AND HEALTHCARE COST
Jang SM1, Park IB2, Suh DC3, Moon KT4, Kim CM5, Kim JY4, 1Health Insurance Review & Assessment Service, Seoul, South Korea, 2Gachon University, Incheon, Incheon, South Korea, 3Rutgers University, Piscataway, NJ, USA, 4Health Insurance Review & Assessment Service, Seoul, Seoul, South Korea, 5Catholic University, Seoul, Suhcho-gu, South Korea

PGI3: VALIDITY OF THE KOREAN VERSION OF THE CHRONIC LIVER DISEASE QUESTIONNAIRE (CLDQ) FOR THE ASSESSMENT OF HEALTHRELATED QUALITY OF LIFE IN KOREAN PATIENTS WITH CHRONIC HEPATITIS B
Choi HM1, Kwon SY2, Kim Y1, Koo HW1, Choi W1, Lee YS1, Lee YS3, Lee JH4, Lee CH2, 1GlaxoSmithKline, Seoul, South Korea, 2Konkuk University, Seoul, South Korea, 3Catholic University of Korea, Bucheon, South Korea, 4Sungkyunkwan University, Seoul, South Korea

PHP11: PRINCIPAL COMPONENTS ANALYSIS OF DRUG UTILIZATION AND EXPENDITURE TRENDS FOR MAJOR THERAPEUTIC CLASSES IN U.S. MEDICAID PROGRAMS
Jing Y1, Nguyen K1, Fan H2, Kelton CM1, Li X3, Guo JJ1, 1University of Cincinnati, Cincinnati, OH, USA, 2Covance Inc, Sun Prairie, WI, USA

PMS5: ECONOMIC EVALUATION ON SCREENING STRATEGIES AND TREATMENT OPTIONS FOR POSTMENOPAUSAL OSTEOPOROSIS
Kingkaew P1, Maleewong U2, Ngarmukos C3, Teerawattananon Y1, 1Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, 2Mahasarakham University, Mahasarakham, Thailand, 3Ramathibodi Hospital, Bangkok, Thailand

PRS6: COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION PHARMACOTHERAPIES IN AUSTRALIA
Bhatti TA1, Makino K1, Guarnieri C1, Gordois A1, Cotter T2, Perez DA2, Bishop JF2, Glass P2, Fong L1, 1IMS Health, St Leonards, New South Wales, Australia, 2Cancer Institute NSW, Eveleigh, New South Wales, Australia

 


  Issues Index | 2008 Issues Index  

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2014 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.